Correct, but it will just become another disease. Flu deaths aren’t really publicized and eventually COVID will be that way too.
OT: Corona virus Questions
- Thread starter FiliUTEP
- Start date
Correct, but it will just become another disease. Flu deaths aren’t really publicized and eventually COVID will be that way too.
"President Donald Trump on Tuesday claimed the European Union was formed to take advantage of the US and argued that the US's European allies had "never treated us well."
[Putin] "This is what you will say to your WH media...."
Environmental News for a Healthier Planet and Life
Help Support EcoWatch
Contribute
CORONAVIRUS
First Trial of Moderna's Coronavirus Vaccine Produces Immune Response in All Participants
Olivia RosaneJul. 15, 2020 07:31AM ESTHEALTH + WELLNESS
The results from Moderna's Phase 1 coronavirus vaccine show it is safe and effective so far. Jakub Porzycki / NurPhoto via Getty Images
Results from the Phase 1 trial of Cambridge, Massachusetts biotech firm Moderna's coronavirus vaccine show it is safe and produces an immune response.
The preliminary report of the trial, published in The New England Journal of Medicine Tuesday, reveals that all 45 participants developed so-called neutralizing antibodies that bind to the virus and stop it from attacking other cells. They developed these antibodies at levels comparable to the upper half of COVID-19 survivors.
"The good news is that this vaccine induced antibodies," director of the National Institute of Allergy and Infectious Diseases Anthony Fauci told Bloomberg News. "Not just any kind of antibodies, but neutralizing antibodies."
Can you get double corona virus? Would it be better to sneeze on the person next to you?
He doesn’t work there anymore. A customer complained that he was using anal beads as a necklace that he wore while working.
No, because he was wearing his anal beads while working. He should have cleaned them and there wouldn’t have been any problems. The customer was being a hater though.
Fili but you’re the one with the Covid already!!!
The point is don’t give it to others!!!
SMH Lol. That means you are already sick. Point is to not spread it. I can't believe there are people that still don't understand this concept.
No. How about change your mask or wash it? How about some common sense on this one.
Your/you're in the store you not sick and only brought 1 mask with you. You sneeze or cough in the mask. Your/ you're in a store that requires you to have a mask on. What should that person do??
Keep it on and suck it up Fili. The point is to stop your germs to going to OTHER people. So, you’re stuck with YOUR germs.
Antibody M is actively positive and G indicates immunity. They need to specify which one.
Both are positive tests though at different phases.
There is also a SARS antigen test so it can be confusing to the media and lay person
World-first research, led by Monash University, has been able to identify positive COVID-19 cases using blood samples in approximately 20 minutes.
In a discovery that could advance the worldwide effort to limit the community spread of COVID-19 through robust contact tracing, researchers were able to identify recent COVID-19 cases using 25 microlitres of plasma from blood samples.
The research team, led by BioPRIA and Monash University’s Chemical Engineering Department, including researchers from the ARC Centre of Excellence in Convergent BioNano Science and Technology (CBNS),developed a simple agglutination assay – an analysis to determine the presence and amount of a substance in blood – to detect the presence of antibodies raised in response to the SARS-CoV-2 infection.
Positive COVID-19 cases caused an agglutination or a clustering of red blood cells, which was easily identifiable to the naked eye. Researchers were able to retrieve positive or negative readings in about 20 minutes.
While the current swab / PCR tests are used to identify people who are currently positive with COVID-19, the agglutination assay can determine whether someone had been recently infected once the infection is resolved – and could potentially be used to detect antibodies raised in response to vaccination to aid clinical trials.
Using a simple lab setup, this discovery could see medical practitioners across the world testing up to 200 blood samples an hour. At some hospitals with high-grade diagnostic machines, more than 700 blood samples could be tested hourly – about 16,800 each day.
Study findings could help high-risk countries with population screening, case identification, contact tracing, confirming vaccine efficacy during clinical trials, and vaccine distribution.
This world-first research was published today (Friday 17 July 2020) in the prestigious journal ACS Sensors.
- World-first research, led by Monash University, has been able to identify positive COVID-19 cases using blood samples in approximately 20 minutes.
- Researchers developed a simple assay based on commonly used blood typing infrastructure. Positive COVID-19 cases cause an agglutination or a clustering of red blood cells, which is easily identifiable.
- This breakthrough can help governments and health experts with contact tracing to limit community spread.
- More than 700 samples can be assessed each hour on high-grade diagnostic machines.
In a discovery that could advance the worldwide effort to limit the community spread of COVID-19 through robust contact tracing, researchers were able to identify recent COVID-19 cases using 25 microlitres of plasma from blood samples.
The research team, led by BioPRIA and Monash University’s Chemical Engineering Department, including researchers from the ARC Centre of Excellence in Convergent BioNano Science and Technology (CBNS),developed a simple agglutination assay – an analysis to determine the presence and amount of a substance in blood – to detect the presence of antibodies raised in response to the SARS-CoV-2 infection.
Positive COVID-19 cases caused an agglutination or a clustering of red blood cells, which was easily identifiable to the naked eye. Researchers were able to retrieve positive or negative readings in about 20 minutes.
While the current swab / PCR tests are used to identify people who are currently positive with COVID-19, the agglutination assay can determine whether someone had been recently infected once the infection is resolved – and could potentially be used to detect antibodies raised in response to vaccination to aid clinical trials.
Using a simple lab setup, this discovery could see medical practitioners across the world testing up to 200 blood samples an hour. At some hospitals with high-grade diagnostic machines, more than 700 blood samples could be tested hourly – about 16,800 each day.
Study findings could help high-risk countries with population screening, case identification, contact tracing, confirming vaccine efficacy during clinical trials, and vaccine distribution.
This world-first research was published today (Friday 17 July 2020) in the prestigious journal ACS Sensors.
